Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    -0.034 (-5.86%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Blocklisting Interim Review

23 Nov 2015 15:42

RNS Number : 6661G
Futura Medical PLC
23 November 2015
Ā 

23 November 2015

Ā 

Ā 

Ā 

Futura Medical plc

("Futura" or "the Company")

Ā 

Block Listing Update

Ā 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in May 2015, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans. All ordinary shares of 0.2 pence each.

The table below provides further detail.

Ā 

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")EMI Share Option Scheme ("EMI")

Ā 

Period of return:

From:

12 May 2015

To:

23 November 2015

Ā 

Number and class of securities not issued under the scheme(s)

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

Ā 

Ā 

Number of securities issued under the scheme(s) during the period

Ā 

Ā 

Number of securities lapsed under the scheme(s) during the period

USOS:

Nil

EMI:

Ā 

Ā 

USOS:

EMI:

Ā 

Ā 

Nil

Ā 

Ā 

Nil

Nil

Ā 

Ā 

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

Ā 

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

USOS Total:

Ā 

2,016,704

EMI:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013

EMI Total:

2,988,296

Total:

5,005,000

Ā 

Ā 

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

Ā 

Ā 

For further information please contact:

Ā 

Futura Medical plc

Ā 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

Ā 

N+1 Singer (Nominated Adviser and Broker)

Ā 

Aubrey Powell / Liz Yong / Tom SmaleCorporate Finance

Ā 

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

Ā 

Buchanan

Ā 

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

Ā 

Ā 

Notes to Editors

Ā 

Futura Medical plc

Ā 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Ā 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
BLREXLFLEFFXFBX
Date   Source Headline
24th Jun 20207:00 amRNSTrading Statement
9th Jun 20202:06 pmRNSSecond Price Monitoring Extn
9th Jun 20202:00 pmRNSPrice Monitoring Extension
1st Jun 20207:00 amRNSBlock listing Interim Review
28th May 20204:40 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
19th May 20204:40 pmRNSSecond Price Monitoring Extn
19th May 20204:35 pmRNSPrice Monitoring Extension
19th May 20202:00 pmRNSPrice Monitoring Extension
19th May 202011:05 amRNSSecond Price Monitoring Extn
19th May 202011:00 amRNSPrice Monitoring Extension
18th May 20207:00 amRNSNotice of AGM and Annual Report
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:36 pmRNSPrice Monitoring Extension
22nd Apr 20203:13 pmRNSDirector/PDMR Shareholding
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSFutura files for Further Pre-Submission meeting
16th Apr 20202:00 pmRNSPrice Monitoring Extension
16th Apr 202011:05 amRNSSecond Price Monitoring Extn
16th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20204:41 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSFutura Confirms Receipt of US FDA Minutes
1st Apr 20207:00 amRNSFull Year Results for the year ended 31 Dec 2019
16th Mar 20207:00 amRNSNotice of Results
5th Mar 20207:00 amRNSFutura to Update on MED3000 at Investor Seminar
27th Feb 20209:37 amRNSHolding(s) in Company
17th Feb 202012:53 pmRNSHolding(s) in Company
13th Feb 20207:00 amRNSUpdate on positive EU regulatory discussions
30th Jan 20207:00 amRNSTotal Voting Rights
22nd Jan 20202:33 pmRNSRemuneration of NED and Total Voting Rights
21st Jan 20202:17 pmRNSHolding(s) in Company
21st Jan 20201:44 pmRNSHolding(s) in Company
17th Jan 202012:12 pmRNSGM Statement
7th Jan 202011:05 amRNSSecond Price Monitoring Extn
7th Jan 202011:00 amRNSPrice Monitoring Extension
27th Dec 20197:00 amRNSPosting of Circular and Notice of General Meeting
23rd Dec 20197:00 amRNSResult of Fundraising
20th Dec 20194:40 pmRNSSecond Price Monitoring Extn
20th Dec 20194:35 pmRNSPrice Monitoring Extension
20th Dec 20194:31 pmRNSPrimaryBid Offer
20th Dec 20194:30 pmRNSCorporate Update & Proposed Fundraising
17th Dec 20194:41 pmRNSSecond Price Monitoring Extn
17th Dec 20194:35 pmRNSPrice Monitoring Extension
17th Dec 201911:05 amRNSSecond Price Monitoring Extn
17th Dec 201911:00 amRNSPrice Monitoring Extension
16th Dec 20199:05 amRNSSecond Price Monitoring Extn
16th Dec 20199:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.